Proprotein Convertase Subtilisin Kexin Type 9 PCSK9 as a New Biomarker for Coronary Artery Disease in an Australian Population

StatusFinished
Effective start/end date1/01/1431/12/14

Funding

  • Royal Perth Hospital Medical Research Foundation